OsmoPrep FDA Approval History
FDA Approved: Yes (First approved March 16, 2006)
Brand name: OsmoPrep
Generic name: sodium phosphate monobasic monohydrate and sodium phosphate dibasic anhydrous
Dosage form: Tablets
Previous Name: INKP-102
Company: Salix Pharmaceuticals, Ltd.
Treatment for: Bowel Preparation
OsmoPrep (sodium biphosphate/sodium phosphate) is a bowel cleansing agent in tablet form, indicated for cleansing of the colon as a preparation for colonoscopy.
Development Timeline for OsmoPrep
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.